Abstract
The aim of this work was to characterize the in vitro behavior of N4- and N3S-RGDS-derivative peptides labeled with 99mTc. Peptides AGGG-Abu-GRGDSPK-NH2 (F22) and C(acm)-GGG-Abu-GRGDSPK-NH2 (SMA1) were synthesized by solid phase. The stability of 99mTc-labeled peptides was assessed in a 30-fold molar excess of cysteine and in plasma. The affinity for plasma proteins was also evaluated. Labeling yield was >95% for both peptides. 99mTc-F22 was not stable in presence of cysteine, but 63% of 99mTc remained chelated to SMA1 up to 24 hours. Both peptides showed low affinity to plasma proteins. N3S-RGDS-derivative peptide (SMA1) showed more stable coordination binding with 99mTc and a higher stability in plasma with regard to N4-RGDS-derivative peptide (F22).
Similar content being viewed by others
References
R. E. Weiner, M. L. Thakur, Sem. Nucl. Med., 31 (2001) 296.
C. Decristoforo, S. J. Mather, Q. J. Nucl. Med., 96 (2002) 195.
T. Qu, Y. Wang, Z. Zhu, M. Rusckowski, D. J. Hnatowich, Nucl. Med. Commun., 22 (2001) 203.
M. A. Stalteri, S. Bansal, R. Hider, S. J. Mather, Bioconjugate Chem., 10 (1999) 130.
J. Lister-James, B. R. Moyer, R. T. Dean, Q. J. Nucl. Med., 41 (1997) 111.
D. Blok, R. I. J. Feitsma, P. Vermeij, E. J. K. Pauwels, Eur. J. Nucl. Med., 26 (1999) 1511.
S. Banerjee, M. Raghavan, A. Pillai, N. Ramamoorthy, Sem. Nucl. Med., 31 (2001) 260.
R. C. Mease, C. Lambert, Sem. Nucl. Med., 31 (2001) 278.
H. P. Vanbilloen, G. M. Borman, M. J. De Roo, A. M. Verbruggen, Nucl. Med. Commun., 22 (1995) 325.
H. P. Vanbilloen, M. J. De Roo, A. M. Verbruggen, Eur. J. Nucl. Med., 23 (1996) 40.
V. R. Pallela, M. L. Thakur, S. Chakder, S. Rattan, J. Nucl. Med., 40 (1999) 352.
M. L. Thakur, V. R. Pallela, P. M. Consigny, P. S. Rao, D. Vessileva-Belnikolovska, R. Shi, J. Nucl. Med., 41(2000) 161.
S. J. Mather, D. Ellison, D. S. Bard, Technetium-99m labeled hybrid receptor-binding peptides, in: Technetium and Rhenium in Chemistry and Nuclear Medicine, M. Nicolini, G. Bandoli, U. Mazzi (Eds), SG Editoriali, Padova, Italy, 1995, p. 383.
C. Decristoforo, S. J. Mather, Bioconjugate Chem., 10 (1999) 431.
R. Haubner, H. J. Wester, U. Reuning, R. Senekowitsch-Schmidtke, B. Diefenbach, H. Kessler, G. Stocklin, M. Schwaiger, J. Nucl. Med., 40 (1999) 1061.
S. M. Albelda, Lab. Invest., 68 (1993) 4.
M. Gurrath, G. Muller, H. Kessler, M. Aumailley, R. Timpl, Eur. J. Biochem., 210 (1992) 911.
Z. Zhu, Y. Wang, Y. Zhang, G. Liu, M. Rusckowski, D. J. Hnatowich, Nucl. Med. Biol., 28 (2001) 703.
I. Kang, D. Kim, Y. Jang, K. Chung, Biochem. Biophys. Res. Commun., 275 (2000) 169.
A. Signore, A. Annovazzi, M. Chianelli, F. Corsetti, C. Van de Wiele, R. N. Watherhouse, F. Scopiaro, Eur. J. Nucl. Med., 28 (2001) 1555.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perera Pintado, A., Mather, S.J., Stalteri, M.A. et al. 99mTc-labeling and in vitro characterization of N4- and N3S-RGDS-derivative peptides. J Radioanal Nucl Chem 275, 619–626 (2008). https://doi.org/10.1007/s10967-007-6867-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-007-6867-y